The History of NxStage Medical
Reports full-year revenue increases to $366 million
on NxStage® System One™
Reports full-year revenue increases to $301.5 million
NxStage begins to expand number of NxStage Kidney Care Centers across the United States
receives clearance for home nocturnal haemodialysis therapy
NxStage opens first Kidney Care dialysis center
Battelle teams wins DARPA contract to build medical device to treat sepsis
NxStage moves to direct sales in Canada and UK
FDA clearance for new high flow capabilities for System One S
CE mark approval for nocturnal home haemodialysis
CE mark approval for high flow capabilities for System One S
Grand opening of new NxStage Headquarters
Distribution agreement with Theradial in Orvault, France.
Distribution agreement with Regional Health Care Group in Rosebery, Australia.
NxStage announces over 5,000 patients using the System One for home haemodialysis
Distribution agreement with Spindial in Lumignano, Italy.
Distribution agreement with Dirinco in Oss, The Netherlands.
Distribution agreement with Nordic MedCom in Boras, Sweden.
Strategic business alliance with Ashai KASEI
NxStage completes its acquisition of Medisystems®
First patients enrolled in the Freedom Study
NxStage goes public
System One receives clearance for home haemodialysis use
System One receives CE clearance for home haemodialysis use